We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HWH:NASDAQHWH International Inc. Analysis

Data as of 2026-08-02 - not real-time

$1.42

Latest Price

9/10Risk

Risk Level: High

Executive Summary

HWH trades at $1.42, which sits above the 20‑day SMA ($1.29) and 50‑day SMA ($1.30) but remains below the 200‑day SMA ($1.48), signaling a short‑term bounce within a longer‑term downtrend. The RSI of 56.7 indicates the stock is not oversold, while a bullish MACD histogram (+0.019) conflicts with the overall bearish trend direction and a decreasing volume profile, suggesting weak momentum. Volatility is extreme at 78.6% over the past 30 days and the Fear & Greed Index reads 92.9 (Extreme Greed), highlighting heightened speculative pressure. Fundamentally, revenue has collapsed by 78% year‑over‑year and operating margins are deeply negative at –9.7%, with a trailing EPS of –$0.40 and no earnings outlook. The DCF‑derived fair value of $0.31 is less than a quarter of the current price, while the price‑to‑book (5.28) and price‑to‑sales (17.25) multiples are markedly inflated. Combined with a max drawdown of –85% and a beta near zero, the stock exhibits severe upside risk but limited downside protection, making it a high‑risk, overvalued position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Price above short‑term SMAs but below long‑term SMA
  • Decreasing volume and bearish trend direction
  • Extreme volatility and speculative market sentiment

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Revenue down 78% and negative operating margin
  • DCF fair value far below market price
  • High debt‑to‑equity ratio and negative cash flow

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained earnings losses and zero dividend
  • Elevated price multiples relative to book and sales
  • High max drawdown and limited liquidity

Key Metrics & Analysis

Financial Health

Revenue Growth-78.30%
ROE-93.89%
ROA-37.01%
Debt/Equity38.75
P/B Ratio5.3
Op. Cash Flow$-1387496
Free Cash Flow$129.9K

Technical Analysis

TrendBearish
RSI56.7
Support$1.13
Resistance$1.49
MA 20$1.29
MA 50$1.30
MA 200$1.48
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair Value$0.31
GradeOvervalued
TypeBlend

Risk Assessment

Beta-0.01
Volatility78.62%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.